Pharma News

(13th August, 2014); Dr Harsh Vardhan, Minister for Health, has clarified that India does not have any confirmed or even suspected Ebola virus affected person. World Health Organization (WHO) had informed that one Indian passenger had travelled on the same flight in which Ebola virus patient (foreign national) was travelling from Monrovia to Lagos. This Indian passenger is back in India. He has been tracked and his health is being regularly monitored. The Health Minister said “We are happy to share that the said person is healthy, fit and fine.”

(7th August, 2014); First time, Scientists are able to cure Rheumatoid arthritis in animals with help of new drug. The researchers are now planning  for human studies to identify the efficacy of the medicinal product in humans.

(7th August, 2014); Electromagnetic stimulation can alter brain organization and it may reprogram your brain for better performance shown by investigators from The University of Western Australia.

(6th August, 2014); Sanofi in India announced today that it has entered into a marketing and distribution agreement with Emcure Pharmaceuticals (Emcure) for its oncology portfolio in India. As per the agreement, while Sanofi will continue to own its oncology range - comprising 4 brands namely Taxotere®, Jevtana®, Fludara® and Fasturtec®, Emcure will market and distribute these brands through its Specialty Unit.

(6th August, 2014); Roche announced on last Monday that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics. This new class of medicines has the potential to address difficult to treat diseases in a range of therapeutic areas.

(6th August, 2014); Central Drugs Standard Control Organization (CDSCO) ensuring uniform procedures in regulatory inspection for issuance of Certificates of Pharmaceutical Products (COPP) and other Good Manufacturing Practices (GMP) inspections. These procedures were discussed in 47^th Drugs consultative committee (DCC) meeting.

(6th August, 2014); Indian Council of Medical Research (ICMR) have initiated a multi-disciplinary cohort study in Delhi and national capital region to find out adverse effects of Radio Frequency Radiation (RFR), if any, emitted from cell phone on adult Indian population.

[adsense:336x280:8701650588]

(5th August, 2014); It is known that data related to antibiotics consumption is not maintained in India. And truly it is hard to obtain such data when everything is mess up around. But it is of utmost importance to capitalize such data to fight with microbial resistance. The concern is growing for antimicrobial resistance in pathogens on account of increased availability and use of antibiotics across the country meant for human, animal and industrial consumption.

(5th August, 2014; Business Wire India); Studies since 2012 have estimated that over 74% of urban Indians are overweight (i.e. BMI over 23 kg/m²). A recent survey conducted by Fitho, a leading wellness services organization that works with partners like Lal Pathlabs, showed that along with increasing weight, there is also increasing awareness and 5 out of 10 urban Indians are trying to lose weight. While 40% of the overweight people have intent to lose weight but are not taking action to control their weight, the remaining 60% are making an effort to lose weight. The survey revealed that looking good, keeping fit and staying confident are the major reasons for the women and men under 35 to lose weight, while people aged over 35 and the heavily overweight (BMI>25 kg/m²) are doing it primarily for a better health.

(1st August, 2014); There are total 968 pharmacy degree institutions (as per section 12) in India as per government updated list of May 2014 with 65,415 seats. And government is working to improve the quality of pharmacy education in India.